MARKET

PRQR

PRQR

Proqr Therapeuti
NASDAQ
1.940
+0.020
+1.04%
After Hours: 1.950 +0.01 +0.52% 19:20 05/17 EDT
OPEN
1.940
PREV CLOSE
1.920
HIGH
2.000
LOW
1.930
VOLUME
64.26K
TURNOVER
0
52 WEEK HIGH
3.290
52 WEEK LOW
1.110
MARKET CAP
158.42M
P/E (TTM)
-5.4357
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at PRQR last week (0506-0510)?
Weekly Report · 6d ago
ProQR Therapeutics Is Maintained at Buy by Chardan Capital
Dow Jones · 05/10 14:24
ProQR Therapeutics Price Target Maintained With a $2.50/Share by Chardan Capital
Dow Jones · 05/10 14:24
Chardan Capital Maintains Buy on ProQR Therapeutics, Maintains $2.5 Price Target
Benzinga · 05/10 14:14
ProQR Therapeutics Price Target Maintained With a $5.00/Share by HC Wainwright & Co.
Dow Jones · 05/10 12:31
HC Wainwright & Co. Reiterates Buy on ProQR Therapeutics, Maintains $5 Price Target
Benzinga · 05/10 12:21
Buy Rating Affirmed for ProQR on Promising RNA Editing Technology and Solid Financial Footing
TipRanks · 05/10 11:57
ProQR’s Axiomer Platform Technology Shows Promise: Analyst Maintains Buy Rating on Robust Editing Efficacy and Clinical Development Potential
TipRanks · 05/10 10:36
More
About PRQR
ProQR Therapeutics N.V. is a pre-clinical stage biopharmaceutical company based in the Netherlands. The Company is engaged in the discovery and development of ribonucleic Acid (RNA)-based therapeutics for the treatment of severe genetic disorders. It designs its therapeutic candidates to specifically target and repair the defective messenger RNA, or Messenger Ribonucleic Acid (mRNA), that is transcribed from a mutated gene in order to restore the expression and function of normal, or wild-type protein. Its product candidates include QR-010, an RNA-based oligonucleotide for the treatment of cystic fibrosis (CF), QR-110, an oligonucleotide and for the treatment of Leber’s congenital amaurosis (LCA).

Webull offers ProQR Therapeutics NV stock information, including NASDAQ: PRQR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRQR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PRQR stock methods without spending real money on the virtual paper trading platform.